| CRKL |
CRKL: Crk-like protein |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
27.950 |
Evidence |
O
|
| U2AF2 |
U2AF2, U2AF65: Splicing factor U2AF 65 kDa subunit |
U2AF1 |
U2AF1, U2AF35, U2AFBP: Splicing factor U2AF 35 kDa subunit |
27.870 |
Evidence |
O
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
27.800 |
Evidence |
O
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
FOXO1A |
FOXO1A, FKHR: Forkhead box protein O1A |
26.890 |
Evidence |
O
|
| ABCD1 |
ABCD1, ALD: ATP-binding cassette sub-family D member 1 |
PEX19 |
PEX19, HK33, OK/SW-cl.22, PXF: Peroxisomal biogenesis factor 19 |
26.550 |
Evidence |
|
| POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
26.470 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
26.470 |
Evidence |
O
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
HDAC2 |
HDAC2: Histone deacetylase 2 |
26.080 |
Evidence |
O
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
25.3 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
25.3 |
Evidence |
O
|
| RB1 |
RB1: Retinoblastoma-associated protein |
CDK4 |
CDK4: Cell division protein kinase 4 |
25.060 |
Evidence |
O
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CCND2 |
CCND2: G1/S-specific cyclin-D2 |
25.030 |
Evidence |
O
|
| TNFRSF10B |
TNFRSF10B, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9: Tumor necrosis factor receptor |
TNFSF10 |
TNFSF10: Uncharacterized protein TNFSF10 |
24.100 |
Evidence |
|
| HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
TBL1XR1 |
TBL1XR1, IRA1, TBLR1: F-box-like/WD repeat-containing protein TBL1XR1 |
23.880 |
Evidence |
|
| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
22.940 |
Evidence |
|
| TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
22.890 |
Evidence |
|
| TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
22.890 |
Evidence |
|
| CHMP6 |
CHMP6, VPS20: Charged multivesicular body protein 6 |
SNF8 |
SNF8, EAP30: Vacuolar-sorting protein SNF8 |
22.690 |
Evidence |
|
| H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
22.450 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
22.290 |
Evidence |
O
|
| JUN |
JUN: Transcription factor AP-1 |
RB1 |
RB1: Retinoblastoma-associated protein |
22.040 |
Evidence |
O
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
20.590 |
Evidence |
O
|
| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
SH3KBP1 |
SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 |
20.550 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
EGF |
EGF: Pro-epidermal growth factor precursor |
19.750 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
RELA |
RELA, NFKB3: Transcription factor p65 |
19.740 |
Evidence |
|
